IBDEI0MR ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11142,0)
 ;;=V10.41^^64^694^58
 ;;^UTILITY(U,$J,358.3,11142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11142,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,11142,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,11142,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,11143,0)
 ;;=V10.05^^64^694^59
 ;;^UTILITY(U,$J,358.3,11143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11143,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,11143,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,11143,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,11144,0)
 ;;=V10.03^^64^694^60
 ;;^UTILITY(U,$J,358.3,11144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11144,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,11144,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,11144,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,11145,0)
 ;;=V10.60^^64^694^62
 ;;^UTILITY(U,$J,358.3,11145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11145,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,11145,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,11145,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,11146,0)
 ;;=V10.11^^64^694^63
 ;;^UTILITY(U,$J,358.3,11146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11146,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,11146,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,11146,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,11147,0)
 ;;=V10.79^^64^694^64
 ;;^UTILITY(U,$J,358.3,11147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11147,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,11147,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,11147,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,11148,0)
 ;;=V10.82^^64^694^65
 ;;^UTILITY(U,$J,358.3,11148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11148,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,11148,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,11148,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,11149,0)
 ;;=V10.02^^64^694^68
 ;;^UTILITY(U,$J,358.3,11149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11149,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,11149,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,11149,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,11150,0)
 ;;=V10.43^^64^694^69
 ;;^UTILITY(U,$J,358.3,11150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11150,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,11150,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,11150,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,11151,0)
 ;;=V10.46^^64^694^70
 ;;^UTILITY(U,$J,358.3,11151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11151,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,11151,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,11151,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,11152,0)
 ;;=V10.06^^64^694^71
 ;;^UTILITY(U,$J,358.3,11152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11152,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,11152,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,11152,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,11153,0)
 ;;=V10.52^^64^694^72
 ;;^UTILITY(U,$J,358.3,11153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11153,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,11153,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,11153,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,11154,0)
 ;;=V10.04^^64^694^74
 ;;^UTILITY(U,$J,358.3,11154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11154,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,11154,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,11154,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,11155,0)
 ;;=V10.47^^64^694^75
 ;;^UTILITY(U,$J,358.3,11155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11155,1,4,0)
 ;;=4^V10.47
